Literature DB >> 7687634

Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide.

A Haziot1, G W Rong, J Silver, S M Goyert.   

Abstract

Recent studies have suggested that soluble CD14 found in serum is involved in the LPS-induced activation of endothelial cells (EC). To more fully investigate the relevance of sCD14 to LPS-induced activation of EC, we have used recombinant soluble CD14 (rsCD14) and have examined, under serum-free conditions, its role in the LPS-induced EC response in the presence of LPS alone as well as in the presence of LPS-binding protein. Our studies show that EC can be activated by high concentrations of LPS in the presence of rsCD14 alone. However, at low concentrations of LPS (5 and 10 ng/ml), the rsCD14-stimulated activation is strongly enhanced by LPS-binding protein. In addition, we show that LPS binds to rsCD14 directly; in the presence of low concentrations of LPS this binding is enhanced by the presence of LPS-binding protein. These results show that while the membrane form of CD14 can function as a receptor, its soluble form can function as a co-ligand with LPS in the EC-LPS response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687634

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.

Authors:  H Loppnow; F Stelter; U Schönbeck; C Schlüter; M Ernst; C Schütt; H D Flad
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

2.  Increased levels of soluble CD14 in sera of periodontitis patients.

Authors:  J Hayashi; T Masaka; I Ishikawa
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 3.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

4.  Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex.

Authors:  Diana Rose E Ranoa; Stacy L Kelley; Richard I Tapping
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

5.  Reproducibility of a novel model of murine asthma-like pulmonary inflammation.

Authors:  L McKinley; J Kim; G L Bolgos; J Siddiqui; D G Remick
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

6.  Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein.

Authors:  J Schletter; H Brade; L Brade; C Krüger; H Loppnow; S Kusumoto; E T Rietschel; H D Flad; A J Ulmer
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 7.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

8.  Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense.

Authors:  Sif Hansdottir; Martha M Monick; Sara L Hinde; Nina Lovan; Dwight C Look; Gary W Hunninghake
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

9.  Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response.

Authors:  Catalina March; Verónica Regueiro; Enrique Llobet; David Moranta; Pau Morey; Junkal Garmendia; José A Bengoechea
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

10.  Activation of human endothelial cells by viable or heat-killed gram-negative bacteria requires soluble CD14.

Authors:  R F Noel; T T Sato; C Mendez; M C Johnson; T H Pohlman
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.